로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > IFN-beta

IFN-beta

요약

Name:Interferon beta
Target Synonym:Interferon Beta 1,Interferon, Beta 1, Fibroblast,IFNB,IFB,IFF,Interferon-beta,IFN-beta,Fibroblast interferon,IFNB1,Interferon beta
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Phase 3 Clinical

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*

Synonym Name

IFNB1,Interferon beta,IFN-beta,IFB,IFNB

Background

Human type I interferons (IFNs) are a large subgroup of interferon proteins that help regulate the activity of the immune system. Interferons bind to interferon receptors. All type I IFNs bind to a specific cell surface receptor complex known as the IFN-¦Á receptor (IFNAR) that consists of IFNAR1 and IFNAR2 chains. The IFN-¦Â proteins are produced in large quantities by fibroblasts. They have antiviral activity that is involved mainly in innate immune response. Two types of IFN-¦Â have been described, IFN-¦Â1 (IFNB1) and IFN-¦Â3 (IFNB3) (a gene designated IFN-¦Â2 is actually IL-6). IFN-¦Â1 is used as a treatment for multiple sclerosis as it reduces the relapse rate. Furthermore, IFN-¦Â1 can bind to a IFNAR1-IFNAR2 heterodimeric receptor, and can also function with IFNAR1 alone and independently of Jak-STAT pathways.

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Dazukibart PF-06823859 Phase 3 Clinical Pfizer Inc Polymyositis; Dermatomyositis; Myositis; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Muscular Diseases Details
Peginterferon beta-1a (CinnaGen) Phase 3 Clinical Cinnagen Multiple Sclerosis, Relapsing-Remitting Details
VSV-IFNbeta-NIS Phase 2 Clinical Vyriad Lymphoma, T-Cell; Carcinoma, Non-Small-Cell Lung; Melanoma; Mycosis Fungoides; Angioimmunoblastic T-cell Lymphoma; Carcinoma, Neuroendocrine; Lymphoma, T-Cell, Cutaneous; Leukemia, Myeloid, Acute; Endometrial Neoplasms; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Colorectal Neoplasms; Sarcoma; Multiple Myeloma; Myelodysplastic Syndromes; Histiocytoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Lymphoma, B-Cell; Solid tumours Details
VSV-hIFNbeta-NIS (University of Tennessee) Phase 1 Clinical The University Of Tennessee Multiple Myeloma; Leukemia, Myeloid, Acute; Endometrial Neoplasms; Lymphoma, T-Cell Details
MEM-288 MEM-288 Phase 1 Clinical Memgen Head and Neck Neoplasms; Solid tumours; Carcinoma, Merkel Cell; Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
SCD-153 SCD-153 Phase 1 Clinical Sun Pharma Advanced Research Company Ltd, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Johns Hopkins University Alopecia Areata Details

This web search service is supported by Google Inc.

totop